common challenges glp-1 users Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Trends: Lifestyle Changes, Dining
Description
Differential associations of dopamine and serotonin with reward and punishment processes in humans: a systematic review and meta-analysis

Patients with a strong family history of obesity, insulin resistance, or metabolic syndrome may be especially responsive to GLP-1 therapy
Then an endocrinologist asked if he'd like to try one of the new class of glucagon-like peptide-1, or GLP-1, drugs that include Wegovy and Mounjaro

This patient cohort was matched with patients with T2DM who did not receive GLP-1 RAs according to age, demographics, comorbidities, and medication by using 1:1 propensity matching
Want help navigating that journey
